Increasing cost and timelines of developing a new drug and lower R&D productivity have compelled global research companies to cut costs. Further, huge amounts of data are being generated as many genomes (besides the human genome) are being sequenced. Handling, storage, retrieval and analysis of these data for their use in new drug discovery and development have necessitated the emergence of sophisticated bioinformatics tools and services.
The ValueNotes / KnowGenix report forecasts that the global bioinformatics market will grow at a CAGR of 16% to touch USD 3.6 billion by 2010. The Indian bioinformatics services outsourcing opportunity is expected to grow at a CAGR of 25% rising from USD 32 million in 2007 to USD 62 million by 2010.
According to Dr R. Rajagopal, CCO, KnowGenix, “India’s success as an IT hub and its growing attractiveness as a contract research and manufacturing (CRAMS) destination is also giving an impetus to the outsourcing of bioinformatics services to India. Research inherently involves the handling, manipulation and analysis of large scale data – hence we believe, vendors providing integrated research-cum-
“India's entry into the product patent regime in 2005 has boosted the confidence of buyers to outsource bioinformatics services to India. However, ambiguity of data security laws could hamper its growth,” cautions, Poonam Bhana, Analyst, ValueNotes. Another key restraint to the growth of this industry is the shortage of experienced bioinformatics professionals. Courses offered by Indian institutes need to be amended to include hands-on experience to ensure that the new batch of the bioinformatics work force is equipped to meet industry needs.
The ValueNotes / KnowGenix report, along with an incisive analysis of the Indian vendor space, aims to provide insights into industry practices and trends, which would help provide a clear picture of the emerging market of bioinformatics outsourcing/
For more information kindly visit: http://www.bharatbook.com/
